| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-08 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.23 | 1e-07 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.19 | 5e-06 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-05 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |